Intended use
This peptide pool is intended for studying immune responses against EBV using immunoassays such as ELISpot, FluoroSpot, and flow cytometry. It induces cytokine secretion from antigen-specific human CD4 and CD8 T cells. For research use only. Not for use in diagnostic procedures.
Description
The EBV peptide pool induces secretion of e.g., IFN-γ and IL-2 from human T cells. It contains 100 peptides derived from 22 of the latent and lytic EBV proteins. Of the peptides, 66 are MHC class I-restricted, and 34 are MHC class II-restricted. The mean purity of the synthetic peptides is 90%.
HLA types covered by the peptide pool:
HLA-A*01, HLA-A*02, HLA-A*03, HLA-A*11, HLA-A*24, HLA-A*25, HLA-A*26, HLA-A*68, HLA-B*07, HLA-B*08, HLA-B*15, HLA-B*18, HLA-B*23, HLA-B*25, HLA-B*26, HLA-B*27, HLA-B*35, HLA-B*38, HLA-B*40, HLA-B*44, HLA-B*55, HLA-B*57, HLA-B*58, HLA-DRB1*01, HLA-DRB1*03, HLA-DRB1*04, HLA-DRB1*07, HLA-DRB1*08, HLA-DRB1*11, HLA-DRB1*13, HLA-DRB1*15, HLA-DRB1*16, HLA-DRB3*01, HLA-DRB3*02, HLA-DRB4*01, HLA-DRB5*01, HLA-DPB1*104, HLA-DPB1*04, HLA-DPB4*01, HLA-DQB1*06, HLA-DQB1*07
